Genomma Lab InternacionalB de CV has a quick ratio of 1.53. It generally indicates good short-term financial strength.
The historical rank and industry rank for Genomma Lab InternacionalB de CV's Quick Ratio or its related term are showing as below:
MEX:LABB'
s Quick Ratio Range Over the Past 10 Years
Min: 0.94 Med: 1.4 Max: 2.95
Current: 1.53
During the past 13 years, Genomma Lab InternacionalB de CV's highest Quick Ratio was 2.95. The lowest was 0.94. And the median was 1.40.
MEX:LABB's Quick Ratio is ranked better than 52.96% of 997
companies
in the Drug Manufacturers industry
Industry Median: 1.45
vs MEX:LABB: 1.53
Genomma Lab InternacionalB de CV (MEX:LABB) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Genomma Lab InternacionalB de CV Quick Ratio Related Terms
Genomma Lab InternacionalB de CV Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genomma Lab InternacionalB de CV Quick Ratio Chart
MEX:LABB vs ZTS, UTHR, VTRS: Quick Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Genomma Lab InternacionalB de CV's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genomma Lab InternacionalB de CV Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Genomma Lab InternacionalB de CV's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Genomma Lab InternacionalB de CV's Quick Ratio falls into.
Genomma Lab InternacionalB de CV Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genomma Lab InternacionalB de CV (MEX:LABB) has a Quick Ratio of 1.53 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Genomma Lab InternacionalB de CV and its competitors. This is near median its historical median of 1.40. Over the past decade, Genomma Lab InternacionalB de CV's Quick Ratio has ranged from 0.94 to 2.95. According to the industry distribution chart, Genomma Lab InternacionalB de CV ranks #469 out of 997 companies in the Drug Manufacturers industry, placing it in the top 47%.
Is Genomma Lab InternacionalB de CV's Quick Ratio too high?
Genomma Lab InternacionalB de CV's current Quick Ratio of 1.53 is near median its 10-year median of 1.40. Over the past 10 years, this metric has ranged from a low of 0.94 to a high of 2.95. The Drug Manufacturers industry median Quick Ratio is 1.45. Genomma Lab InternacionalB de CV's value of 1.53 is 5.5% above this industry median. Based on the distribution chart, Genomma Lab InternacionalB de CV ranks #469 out of 997 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Genomma Lab InternacionalB de CV has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Genomma Lab InternacionalB de CV's Quick Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Genomma Lab InternacionalB de CV ranks #469 out of 997 companies for Quick Ratio. This puts Genomma Lab InternacionalB de CV in the upper half of its industry. The industry median Quick Ratio is 1.45. Genomma Lab InternacionalB de CV's value of 1.53 is 5.5% above this benchmark. Historically, Genomma Lab InternacionalB de CV's own Quick Ratio has ranged from 0.94 to 2.95 over the past decade. While the company's 10-year median is 1.40 vs. the industry median of 1.45, Genomma Lab InternacionalB de CV has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 997 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genomma Lab InternacionalB de CV's current Quick Ratio of 1.53 is 5.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Genomma Lab InternacionalB de CV and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genomma Lab InternacionalB de CV's current Quick Ratio is 1.53, which is near median its own 10-year median of 1.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genomma Lab InternacionalB de CV stock overvalued right now?
Based on GuruFocus' analysis, Genomma Lab InternacionalB de CV (MEX:LABB) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN17.64, compared to a current price of MXN15.04 — trading 14.7% below its estimated fair value. The current Quick Ratio is 1.53, which is near median its 10-year median of 1.40 and 5.5% above the Drug Manufacturers industry median of 1.45. Genomma Lab InternacionalB de CV's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Genomma Lab InternacionalB de CV (MEX:LABB), the current Quick Ratio is 1.53 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Genomma Lab InternacionalB de CV (MEX:LABB) Overvalued in 2026?
Based on GuruFocus' analysis, Genomma Lab InternacionalB de CV stock appears to be undervalued.
The current stock price of MXN15.04 is trading 14.7% below its estimated GF Value™ of MXN17.64.
GuruFocus considers Genomma Lab InternacionalB de CV to be Modestly Undervalued.
Key valuation signals for MEX:LABB:
Quick Ratio: 1.53 (near median its 10-year median of 1.40)
GF Value™: MXN17.64 vs. price of MXN15.04 (14.7% below fair value)
Industry Position: 5.5% above the Drug Manufacturers median (#469 of 997)
No single metric tells the full story. See the MEX:LABB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Genomma Lab InternacionalB de CV Business Description
Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
66GF Score
Get the complete analysis for MEX:LABB
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:LABB has been successfully added to your 
